Skip to main content
. 2020 Oct 7;10:560899. doi: 10.3389/fcimb.2020.560899

Table 1.

Sociodemographic characteristics of pregnant COVID-19 patients and control group.

COVID-19 patients Control patients P
N (%)/N ± SD N (%)/N ± SD
Age 30.97 ± 4.13 29.97 ± 3.43 0.0871
Parity
  1 40 (66.67) 80 (66.67)
  2 19 (31.67) 38 (31.67)
  3 1 (1.67) 2 (1.67)
Fetus number
  1 59 (98.33) 118 (98.33)
  2 1 (1.67) 2 (1.67)
Chronic disease
  None 36 (60.00) 72 (60.00)
  Diabetes 10 (16.67) 20 (16.67)
  Hypertension 8 (13.33) 16 (13.34)
  Diabetes and hypertension 3 (5.00) 6 (5.00)
  Hypothyroidism 2 (3.33) 4 (3.33)
  Hepatic disease 1 (1.67) 2 (1.67)
  Gestational week of delivery 37.87 ± 2.36 38.81 ± 1.81 0.0078
Gestational week of delivery
  <37 10 (16.67) 9 (7.50) 0.0599
  ≥37 50 (83.33) 111 (92.50)
Delivery
  Vaginal delivery 17 (28.33) 69 (57.50) 0.0002
  Cesarean delivery 43 (71.67) 51 (42.50)
First symptoms
  None 26 (28.33) 0
  Fever before or during delivery 11 (18.33) 0
  Fever after delivery 23 (38.33) 0
  Respiratory symptoms 9 (15.00) 0
  Neonatal birthweight (g) 3220 ± 622 3251 ± 520 0.7247
1-min Apgar scores
  10 38 (63.33) 14 (58.33) 0.5152
  <10 22 (36.67) 10 (41.67)
5-min Apgar scores
  10 57 (95.00) 23 (95.83) 0.8105
  <10 3 (5.00) 1 (4.17)